SYK Stryker Corporation
Healthcare · Medical Devices
319.13
-1.59%
About the company
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
52-week range
Dividend deep dive
Stryker Corporation (SYK) is a Healthcare company in the Medical Devices industry. It currently offers a dividend yield of 1.1%, which is above its 5-year average yield band of 0.22% to 0.3%. Yield Theory suggests the stock is undervalued, while one Fair Value model indicates it is slightly undervalued by 6.0% and another suggests it is expensive. The company has a 16-year streak of dividend increases, qualifying it as a CCC 'Contender' for dividend consistency.
Dividend history
Stryker Corporation has increased its dividend for 16 consecutive years, demonstrating consistency. The 3-year dividend growth rate is 6.52% and the 5-year CAGR is 7.88%, indicating steady growth. The annual dividend history shows consistent increases: $0.305 in 2014, $0.345 in 2015, $0.38 in 2016, $0.425 in 2017, $0.47 in 2018, $0.52 in 2019, $0.575 in 2020, $0.63 in 2021, $0.695 in 2022, $0.75 in 2023, and projected $0.80 in 2024 and $0.84 in 2025. Dividends are paid quarterly in March, June, September, and December.
Dividend safety
The dividend appears well-covered, with a payout ratio of 37.49% based on EPS. Leverage is moderate, with a debt-to-equity ratio of 65.793%. The company holds $3.27 billion in cash against $15.43 billion in total debt.
Quantic · Free
Read the rest of the safety verdict
Plus the key risks and what to watch next — free, no card.
AI-generated from Quantic's dividend data · Updated 11 Nov 2026 · Information, not financial advice.
Price history
Dividend profile
Yield band A stock's current dividend yield shown against its own range over the past five years — the low, average and high. Near the high end the shares look relatively cheap for the income they pay; near the low end, relatively expensive. It's the picture behind Dividend Yield Theory. Learn more → (5-year)
Ex-dividend date The cut-off day: you must already own the stock before it to receive the next dividend. Buy on or after, and the seller keeps that payment. Learn more →
The cash usually arrives later, sometimes a month or more after.
Dividend history
Per-share dividend by year
Debt & leverage
Latest reported balance-sheet figures.
watched by 1
Appears in these lists
SYK qualifies for these curated dividend rankings.
New to dividend investing?
Information, not financial advice.
Quantic · Free
Track SYK and your whole portfolio
Real yield, dividend safety, net-of-tax income and your path to freedom — free, no broker connection.
Need more? Pro adds portfolios, options income tracking & more AI. See Pro →